Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of SPP635 in type 2 diabetes with hypertension and albuminuria
2007-004559-12Phase 2Completed
- Sponsor
- Speedel
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of SPP 635 in hypertension (HTN) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Speedel. Primary endpoint: Change in ambulatory blood pressure. Started Sep 2007; status: completed.
02
Drugs
SPP 635
03
Conditions
hypertension (HTN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-004559-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004559-12.